Combined Modality Therapy of Esophageal Cancer: Changes in the Standard of Care?
368 Downloads 200 Citations 9 Comments
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
- Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:4–66.
- Iyer R, Wilkinson N, Demmy T, Javle M. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy. Ann Surg Oncol 2004;11:665–74.
- Birkmeyer JD, et al. Surgical volume and operative mortality in the United States. N Engl J Med 2003;349:2117–27. CrossRef
- Hulscher JB, et al. Extending transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662–9. CrossRef
- Herskovic A, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593–8. CrossRef
- al-Sarraf M, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997;15:277–84.
- Minsky B, et al. INT 0123 (Radiation Therapy Oncology Group 94--05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167–74.
- Bedenne L, et al. Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone. (FFCD 9102) (abst 519). Proceedings of the American Society of Clinical Oncology 2002;21:130.
- Burmeister BH, et al. A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus (abst. 518). Proceedings of the American Society of Clinical Oncology 2002;21:130.
- Stahl M, et al. Randomized phase III trial in locally advanced squamous cell carcinoma (SCC) of the esophagus: chemoradiation with and without surgery (abst 1001). Proceedings of the American Society of Clinical Oncology 2003;22:250.
- Medical Research Council. Surgical Resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727–33.
- Kelsen DP, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979–84. CrossRef
- Ando N, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan clinical oncology group study—JCOG9204. J Clin Oncol 2003;21:4592–96.
- MacDonald J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725–30. CrossRef
- Hurwitz H, etal. Bevacizumab (a monoclonal antibody to vascular endothelial growth factor) prolongs survival in first line colorectal cancer (CRC): Results of a phase III trial of bevacizumab in combination with bolus IFL (irinotecan, 5-fluorouracil, leucovorin) as first-line therapy in subjects with metastatic CRC. Proceedings of the American Society of Clinical Oncology 2003.
- Weber W, et al. Prediction of response to preoperative chemotherapy in adenocarcinoma of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058–65.
- Combined Modality Therapy of Esophageal Cancer: Changes in the Standard of Care?
Annals of Surgical Oncology
Volume 11, Issue 7 , pp 641-643
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links